Business Context and Reporting Period
Company: Daré Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 22, 2020
Event: Entry into a Material Definitive Agreement (Purchase Agreement) and Registration Rights Agreement with Lincoln Park Capital Fund, LLC.
Key Financial Metrics and Transaction Terms
This filing details a financing arrangement rather than reporting periodic financial results (revenue, profit, or cash flow). Key transaction metrics include:
- Total Commitment: Lincoln Park committed to purchase up to $15.0 million in shares of common stock.
- Initial Issuance: 285,714 shares of common stock issued on April 22, 2020, as consideration for the commitment.
- Term: 36-month period commencing on the "Commencement Date" (upon SEC registration effectiveness).
- Purchase Mechanism:
- Commencement Purchase: Up to $500,000 on the Commencement Date.
- Regular Purchases: Up to 200,000 shares per business day (increasing to 250,000 or 300,000 shares if stock price is $\ge$ $1.50 or $\ge$ $3.00, respectively), capped at $1,000,000 per purchase.
- Pricing: Lower of (i) lowest sale price on the purchase day or (ii) average of the three lowest closing prices in the preceding 10 business days.
- Exchange Cap: Issuance limited to 19.99% of pre-transaction outstanding shares (4,941,089 shares) unless shareholder approval is obtained or specific pricing thresholds are met.
- Use of Proceeds: Working capital and general corporate purposes.
Material Changes and Agreements
The primary material change is the establishment of an "at-the-market" style equity financing facility. Key contractual provisions include:
- Discretionary Sales: Daré has the right, but not the obligation, to sell shares; Lincoln Park is obligated to purchase if directed, subject to conditions.
- Lock-up on Variable Rate Transactions: Daré agreed not to enter into other variable rate transactions for 36 months.
- Short Selling Restriction: Lincoln Park agreed not to engage in short selling or hedging of Daré's common stock during the term.
- Termination: Daré may terminate the agreement at any time after the Commencement Date without penalty. The agreement terminates automatically in the event of bankruptcy.
- Beneficial Ownership Limit: Sales cannot result in Lincoln Park beneficially owning more than 9.99% of outstanding shares.
Guidance, Risks, and Contingencies
Management Commentary: The company expects to use proceeds for working capital. The actual net proceeds depend on market conditions, trading price, and the frequency of sales initiated by the company.
Risks and Contingencies:
- Forward-Looking Statements: Actual results may differ due to R&D risks, regulatory approval processes, and stock market volatility.
- Registration Requirement: The ability to sell shares is contingent on the SEC declaring a registration statement effective and filing a final prospectus (targeted by May 22, 2020).
- Nasdaq Compliance: Issuances are strictly limited by Nasdaq rules regarding the 19.99% exchange cap.
- Default Events: Sales cannot be initiated if an event of default exists until cured.
Investor Verification Checklist
- Verify the effectiveness date of the registration statement filed with the SEC to determine the actual "Commencement Date."
- Monitor the trading price of DARE stock to assess potential dilution under the pricing formula (lower of current low or 10-day average low).
- Review subsequent filings to track the volume of shares sold under the Purchase Agreement and total proceeds raised.
- Check for any announcements regarding shareholder approval to exceed the 19.99% Exchange Cap.
- Confirm the company's cash position and burn rate to evaluate the necessity of utilizing this facility.